When does injectable naltrexone patent expire?

When does the injectable naltrexone patent expire?

The exact “injectable naltrexone” patent expiry depends on which product you mean (for example, XR-naltrexone used for opioid or alcohol use disorder) and which specific patent(s) you’re tracking. Patent expiry dates can also differ by country and by whether you’re looking at the first composition/patent filing, later reformulations, or pediatric/exclusivity-related extensions.

What determines the patent expiry date for injectable naltrexone?

Patent expiry timing usually turns on several factors:
- Jurisdiction (US vs. EU vs. other countries).
- Which patent family is being referenced (original active ingredient vs. specific long-acting formulation/device/process).
- Legal events like patent term adjustments or litigation outcomes that can shift enforceability dates.

What can users mean by “injectable naltrexone” in searches?

People often search one of these:
- Extended-release injectable naltrexone (the commonly referenced long-acting product).
- Other long-acting injectable naltrexone formulations.
Because “injectable naltrexone” can map to multiple related products, the expiry date can change.

How can I find the exact expiry date you need?

To give a precise date, I need one detail:
- Which country (e.g., US)?
- Which product name or manufacturer (e.g., the specific branded injectable naltrexone in that market)?

If you tell me the product name and country, I can pinpoint the relevant patent(s) and the expected expiry date(s).